-
1
-
-
0037165261
-
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma
-
Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med 2002;346:235-42.
-
(2002)
N Engl J Med
, vol.346
, pp. 235-242
-
-
Coiffier, B.1
Lepage, E.2
Briere, J.3
Herbrecht, R.4
Tilly, H.5
Bouabdallah, R.6
Morel, P.7
-
2
-
-
33646004738
-
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large B-cell lymphoma: A randomised controlled trial by the MabThera International Trial (MInT) Group
-
Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K, Ma D, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 2006;7:379-91.
-
(2006)
Lancet Oncol
, vol.7
, pp. 379-391
-
-
Pfreundschuh, M.1
Trumper, L.2
Osterborg, A.3
Pettengell, R.4
Trneny, M.5
Imrie, K.6
Ma, D.7
-
3
-
-
33845719408
-
Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP
-
Lin PC, Hsiao LT, Poh SB, Wang WS, Yen CC, Chao TC, Liu JH, et al. Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP. Ann Hematol 2007; 86:95-100.
-
(2007)
Ann Hematol
, vol.86
, pp. 95-100
-
-
Lin, P.C.1
Hsiao, L.T.2
Poh, S.B.3
Wang, W.S.4
Yen, C.C.5
Chao, T.C.6
Liu, J.H.7
-
4
-
-
33645984821
-
Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkin's lymphoma patient
-
Unluturk U, Aksoy S, Yonem O, Bayraktar Y, Tekuzman G. Cytomegalovirus gastritis after rituximab treatment in a non-Hodgkin's lymphoma patient. World J Gastroenterol 2006;12: 1978-9.
-
(2006)
World J Gastroenterol
, vol.12
, pp. 1978-1979
-
-
Unluturk, U.1
Aksoy, S.2
Yonem, O.3
Bayraktar, Y.4
Tekuzman, G.5
-
5
-
-
0037481814
-
Pneumocystis carinii pneumonia in patients with hematologic malignancies: A descriptive study
-
Roblot F, Le MG, Godet C, Hutin P, Texereau M, Boyer E, Prazuck T, et al. Pneumocystis carinii pneumonia in patients with hematologic malignancies: a descriptive study. J Infect 2003; 47:19-27.
-
(2003)
J Infect
, vol.47
, pp. 19-27
-
-
Roblot, F.1
Le, M.G.2
Godet, C.3
Hutin, P.4
Texereau, M.5
Boyer, E.6
Prazuck, T.7
-
6
-
-
0036253761
-
Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres
-
Pagano L, Fianchi L, Mele L, Girmenia C, Offidani M, Ricci P, Mitra ME, et al. Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres. Br J Haematol 2002;117:379-86.
-
(2002)
Br J Haematol
, vol.117
, pp. 379-386
-
-
Pagano, L.1
Fianchi, L.2
Mele, L.3
Girmenia, C.4
Offidani, M.5
Ricci, P.6
Mitra, M.E.7
-
7
-
-
16344383475
-
Pneumocystis carinii pneumonia in patients with solid tumors and lymphomas: Predisposing factors and outcome
-
Barbounis V, Aperis G, Gambletsas E, Koumakis G, Demiris M, Vassilomanolakis M, Efremidis A. Pneumocystis carinii pneumonia in patients with solid tumors and lymphomas: predisposing factors and outcome. Anticancer Res 2005;25:651-5.
-
(2005)
Anticancer Res
, vol.25
, pp. 651-655
-
-
Barbounis, V.1
Aperis, G.2
Gambletsas, E.3
Koumakis, G.4
Demiris, M.5
Vassilomanolakis, M.6
Efremidis, A.7
-
8
-
-
33645983193
-
Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: A phase II study of feasibility and toxicity
-
Brusamolino F, Rusconi C, Montalbetti L, Gargantini L, Uziel L, Pinotti G, Fava S, et al. Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity. Haematologica 2006; 91:496-502.
-
(2006)
Haematologica
, vol.91
, pp. 496-502
-
-
Brusamolino, F.1
Rusconi, C.2
Montalbetti, L.3
Gargantini, L.4
Uziel, L.5
Pinotti, G.6
Fava, S.7
-
9
-
-
0031227964
-
guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America
-
Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, Pizzo P, et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis 1997; 25:551-73.
-
(1997)
Clin Infect Dis
, vol.1997
, Issue.25
, pp. 551-573
-
-
Hughes, W.T.1
Armstrong, D.2
Bodey, G.P.3
Brown, A.E.4
Edwards, J.E.5
Feld, R.6
Pizzo, P.7
-
10
-
-
33344466718
-
Guidelines for the use of antimicrobial agents in patients with febrile neutropenia in Taiwan
-
Guidelines for the use of antimicrobial agents in patients with febrile neutropenia in Taiwan. J Microbiol Immunol Infect 2005;38:455-7.
-
(2005)
J Microbiol Immunol Infect
, vol.38
, pp. 455-457
-
-
-
11
-
-
0026783577
-
Pneumocystis carinii pneumonitis following bone marrow transplantation
-
Tuan IZ, Dennison D, Weisdorf DJ. Pneumocystis carinii pneumonitis following bone marrow transplantation. Bone Marrow Transplant 1992;10:267-72.
-
(1992)
Bone Marrow Transplant
, vol.10
, pp. 267-272
-
-
Tuan, I.Z.1
Dennison, D.2
Weisdorf, D.J.3
-
12
-
-
22244461829
-
Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen
-
Tsimberidou AM, Younes A, Romaguera J, Hagemeister FB, Rodriguez MA, Feng L, Ayala A, et al. Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen. Cancer 2005;104:345-53.
-
(2005)
Cancer
, vol.104
, pp. 345-353
-
-
Tsimberidou, A.M.1
Younes, A.2
Romaguera, J.3
Hagemeister, F.B.4
Rodriguez, M.A.5
Feng, L.6
Ayala, A.7
-
13
-
-
0029991369
-
Fludarabine, mitoxantrone, and dexamethasone: An effective new regimen for indolent lymphoma
-
McLaughlin P, Hagemeister FB, Romaguera JE, Sarris AH, Pate O, Younes A, Swan F, et al. Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma. J Clin Oncol 1996;14:1262-8.
-
(1996)
J Clin Oncol
, vol.14
, pp. 1262-1268
-
-
McLaughlin, P.1
Hagemeister, F.B.2
Romaguera, J.E.3
Sarris, A.H.4
Pate, O.5
Younes, A.6
Swan, F.7
-
14
-
-
0029965329
-
Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/ sulfamethoxazole
-
Korraa H, Saadeh C. Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/ sulfamethoxazole. South Med J 1996;89:272-7.
-
(1996)
South Med J
, vol.89
, pp. 272-277
-
-
Korraa, H.1
Saadeh, C.2
-
15
-
-
0026601038
-
Salvage therapy with clindamycin/primaquine for Pneumocystis carinii pneumonia
-
Noskin GA, Murphy RL, Black JR, Phair JP. Salvage therapy with clindamycin/primaquine for Pneumocystis carinii pneumonia. Clin Infect Dis 1992;14:183-8.
-
(1992)
Clin Infect Dis
, vol.14
, pp. 183-188
-
-
Noskin, G.A.1
Murphy, R.L.2
Black, J.R.3
Phair, J.P.4
|